Published On : Mon, Apr 12th, 2021

Sputnik-V vaccine gets nod for use in India

Advertisement

Russia’s Covid vaccine Sputnik-V has been cleared for emergency use approval in India by a committee of experts in the middle of a record spike in virus cases in the country.

If approved by regulator DGCI, this will become the third vaccine to be used in India after Serum Institute of India’s Covishield – developed by Oxford-AstraZeneca – and Bharat Biotech’s Covaxin.

Gold Rate
21 Oct 2025
Gold 24 KT ₹ 1,22,500 /-
Gold 22 KT ₹ 1,13,900 /-
Silver/Kg ₹ 1,53,000/-
Platinum ₹ 60,000/-
Recommended rate for Nagpur sarafa Making charges minimum 13% and above

Sputnik-V, manufactured in India by Dr Reddy’s, has the highest effectiveness – 91.6 per cent — after the Moderna and Pfizer shots.

Advertisement
Advertisement